Lumasiran 94.5mg/0.5ml solution for injection vials
NHS hospitals in England used £24,417,821 of indicative cost of Lumasiran 94.5mg/0.5ml solution for injection vials in the 12 months to April 2026, about 0.1% of all hospital medicines spend. That is up 19.4% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Lumasiran 94.5mg/0.5ml solution for injection vials: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Lumasiran 94.5mg/0.5ml solution for injection vials most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Univ Hpl B/Ham Nhs Foundation Trust | £6,290,105 |
| Royal Free London Nhs Foundation Trust | £2,748,104 |
| Nottingham University Hospitals Trust | £1,709,931 |
| Leeds Teaching Hpls Nhs Trust | £1,465,656 |
| Manchester University Nhs Ft | £661,988 |
| Birmingham Womans & Childrens Nhs Ft | £549,621 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £488,552 |
| Guy's & St Thomas' Nhs Foundation Trust | £366,414 |
| University Hpls Of Leicester Nhs Trust | £244,276 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.